Close Menu

U.S. Food and Drug Administration Regulatory Affairs

11:00 am to 12:30 pm

As part of our ongoing initiative to promote innovation, commercialization and industry partnerships, BIO5 will host an introduction to regulatory affairs by the Critical Path Institute (C-Path). Speakers Dr. Huong Huynh and Dr. Maaike Everts will provide an overview over the regulatory science program at C-Path as well as their newly established Translational Therapeutics Accelerator (TRxA). Please join us to learn about and explore pathways to achieving regulatory endorsement for drug development and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. This free event takes place over Zoom and registration is required.

Headquartered in Tucson, C-Path is an independent, nonprofit organization that is working to transform the world of medical product development. We innovate through collaboration, providing an open, precompetitive forum in which industry leaders, regulators, scientists, academic researchers and patient groups work together to accelerate the development of new therapies.

To request any disability-related accommodations for this event please contact the event coordinator at least three business days prior to the event.
11:00 am to 12:30 pm
Thursday, August 11, 2022 - 11:00am


Faculty, Staff
University of Arizona Health Sciences




Uwe Hilgert
BIO5 Institute